ConductScience.org, home

Paper42536166

Do Current Endpoints Underestimate Benefit in MeVO Stroke? A Call for Cognitive Profiling.

Rus Prelog P and 3 others. Clin Neuroradiol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Do Current Endpoints Underestimate Benefit in MeVO Stroke? A Call for Cognitive Profiling. Papers, record 42536166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42536166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Do Current Endpoints Underestimate Benefit in MeVO Stroke? A Call for Cognitive Profiling.
PubMed
Journal
Clin Neuroradiol
PubMed
Year
2026
PubMed
Publication types
Letter
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-07-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rus Prelog PPolona
2Zupan MMatija
3Chapot RRené
4Frol SSentahttps://orcid.org/0000-0001-9494-160X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132486967Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion: A Population-Based Study (Dijon Stroke Registry).Stroke2020https://conductscience.org/library/papers/32486967PubMed
239908448Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.N Engl J Med2025https://conductscience.org/library/papers/39908448PubMed
339908430Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels.N Engl J Med2025https://conductscience.org/library/papers/39908430PubMed
442127389Endovascular Treatment of Medium-Vessel-Occlusion Strokes.N Engl J Med2026https://conductscience.org/library/papers/42127389PubMed
534501552Current Update on the Clinical Utility of MMSE and MoCA for Stroke Patients in Asia: A Systematic Review.Int J Environ Res Public Health2021https://conductscience.org/library/papers/34501552PubMed
636478766Validation of the UK English Oxford cognitive screen-plus in sub-acute and chronic stroke survivors.Eur Stroke J2022https://conductscience.org/library/papers/36478766PubMed
740406877StrokeCog-15 Is an Efficient Neuropsychological Battery to Screen for Cognitive Impairment in Chronic Stroke.Stroke2025https://conductscience.org/library/papers/40406877PubMed
841614516The mini-Oxford cognitive screen (Mini-OCS): A very brief cognitive screen for use in chronic stroke.Eur Stroke J2026https://conductscience.org/library/papers/41614516PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42536166

GET https://conductscience.org/api/papers/v1/42536166/authors